Who
Joseph Douglas Lyon
Officer
Company insider
Files Form 4 as: Chief Accounting Officer, Corcept Therapeutics.
In numbers
- Trades disclosed
- 215
- Buys
- 0
- Sells
- 44
- Bought
- $0
- Sold
- $34.1M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 13 Jul 2020
- Last trade
- 2 Oct 2026
- Last filed
- 5 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Oct 2026filed 5 Oct 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Code M | $46K3,357 at $13.56 | filing |
| 2 Oct 2026filed 5 Oct 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Code M | $112K5,833 at $19.26 | filing |
| 2 Oct 2026filed 5 Oct 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $514K4,446 at $115.70 | filing |
| 2 Oct 2026filed 5 Oct 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $553K4,744 at $116.54 | filing |
| 2 Oct 2026filed 5 Oct 2026 | CORT Corcept Therapeuticsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —3,357 at $0.00 | filing |
| 2 Oct 2026filed 5 Oct 2026 | CORT Corcept Therapeuticsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —5,833 at $0.00 | filing |
| 1 Oct 2026filed 5 Oct 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Code M | $11K810 at $13.56 | filing |
| 1 Oct 2026filed 5 Oct 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $93K810 at $115.40 | filing |
| 1 Oct 2026filed 5 Oct 2026 | CORT Corcept Therapeuticsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —810 at $0.00 | filing |
| 14 Sep 2026filed 16 Sep 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Code M | $29K2,596 at $11.35 | filing |
| 14 Sep 2026filed 16 Sep 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Code M | $100K7,404 at $13.56 | filing |
| 14 Sep 2026filed 16 Sep 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $885K7,812 at $113.32 | filing |
| 14 Sep 2026filed 16 Sep 2026 | CORT Corcept Therapeuticsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —2,596 at $0.00 | filing |
| 14 Sep 2026filed 16 Sep 2026 | CORT Corcept Therapeuticsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —7,404 at $0.00 | filing |
| 14 Sep 2026filed 16 Sep 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $250K2,188 at $114.12 | filing |
| 14 Sep 2026filed 16 Sep 2026 | CORT Corcept Therapeuticsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —2,596 at $0.00 | filing |
| 14 Sep 2026filed 16 Sep 2026 | CORT Corcept Therapeuticsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —7,404 at $0.00 | filing |
| 14 Sep 2026filed 16 Sep 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Code M | $29K2,596 at $11.35 | filing |
| 14 Sep 2026filed 16 Sep 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Code M | $100K7,404 at $13.56 | filing |
| 14 Sep 2026filed 16 Sep 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $885K7,812 at $113.32 | filing |
News
Corcept Therapeutics (NASDAQ:CORT) Stock: Insider Joseph Douglas Lyon Sells 9,190 Sharesdailypolitical.com · 6 Oct 2026
1 headline in the last 90 days name Joseph Douglas Lyon; 0 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.